These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18536683)

  • 1. Patent protection and access to genetic resources.
    Shimbo I; Ito Y; Sumikura K
    Nat Biotechnol; 2008 Jun; 26(6):645-7. PubMed ID: 18536683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patenting applied to genetic sequence information.
    Duval M; Hsieh TF
    Biotechnol Genet Eng Rev; 2006; 23():317-30. PubMed ID: 22530515
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology patents under fire.
    Royzman I
    Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959
    [No Abstract]   [Full Text] [Related]  

  • 5. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 6. US court case to define EST patentability.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
    [No Abstract]   [Full Text] [Related]  

  • 7. Patenting the parts.
    Nat Biotechnol; 2007 Aug; 25(8):822. PubMed ID: 17687343
    [No Abstract]   [Full Text] [Related]  

  • 8. The level of disclosure necessary for patent protection of genetic innovations.
    Berman RJ; El Schoenhard A
    Nat Biotechnol; 2004 Oct; 22(10):1307-8. PubMed ID: 15470468
    [No Abstract]   [Full Text] [Related]  

  • 9. A nail in the coffin for DNA sequence patents?
    Yamanaka M
    Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072
    [No Abstract]   [Full Text] [Related]  

  • 10. The obviousness rejection as a barrier to biotech patent prosecution.
    Wang SJ
    Nat Biotechnol; 2009 Dec; 27(12):1125-6. PubMed ID: 20010590
    [No Abstract]   [Full Text] [Related]  

  • 11. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA patenting: the end of an era?
    Hopkins MM; Mahdi S; Patel P; Thomas SM
    Nat Biotechnol; 2007 Feb; 25(2):185-7. PubMed ID: 17287750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From human genes to stem cells: new challenges for patent law?
    Caulfield TA
    Trends Biotechnol; 2003 Mar; 21(3):101-3. PubMed ID: 12628363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 15. Parts, property and sharing.
    Henkel J; Maurer SM
    Nat Biotechnol; 2009 Dec; 27(12):1095-8. PubMed ID: 20010583
    [No Abstract]   [Full Text] [Related]  

  • 16. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 17. Patentability of synthetic biology inventions in Europe.
    Rutz B
    Biotechnol J; 2010 Jan; 5(1):11-3. PubMed ID: 20069577
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing emphasis in test for patent infringement.
    Moran P
    Med Device Technol; 2005 Mar; 16(2):28. PubMed ID: 15828498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotechnology and the new property regime in human bodies and body parts.
    Nwabueze RN
    Loyola Los Angel Int Comp Law J; 2002 Jan; 24(1):19-64. PubMed ID: 12769112
    [No Abstract]   [Full Text] [Related]  

  • 20. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.